⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL457323 | 1.00 | — | — | |
| SCHEMBL9508954 | 0.78 | — | — | |
| SCHEMBL12663707 | 0.77 | — | — | |
| SCHEMBL9508961 | 0.75 | — | — | |
| SCHEMBL3118205 | 0.75 | — | — | |
| SCHEMBL18767507 | 0.73 | — | — | |
| SCHEMBL21437001 | 0.73 | — | — | |
| SCHEMBL5689289 | 0.73 | — | — | |
| SCHEMBL7361273 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL5693195 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020023386-A1 | GIP/GLP1 CO-AGONIST COMPOUNDS | ELI LILLY AND COMPANY (US) | 2020-01-30 | — | — | WO | disclosed |
| WO-2020023388-A1 | METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES | ELI LILLY AND COMPANY (US) | 2020-01-30 | — | — | WO | disclosed |